Singapore markets closed
Straits Times Index
3,287.75 -5.38 (-0.16%) S&P 500
4,994.08 -77.55 (-1.53%) Dow
37,766.40 -694.52 (-1.81%) Nasdaq
15,394.62 -318.13 (-2.02%) Bitcoin USD
63,457.41 -2,546.99 (-3.86%) CMC Crypto 200
1,373.59 -8.98 (-0.65%)
Innovative Pharmaceutical Biotech Limited (0399.HK)
HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
At close: 02:23PM HKT
Currency in HKD
Valuation measures4
| Market cap (intra-day) | 342.92M |
| Enterprise value | 1.34B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 41.73 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 174.56 |
| Enterprise value/EBITDA | 4.30 |
Trading information
Stock price history
| Beta (5Y monthly) | -0.12 |
| 52-week change 3 | -1.97% |
| S&P500 52-week change 3 | 22.64% |
| 52-week high 3 | 0.370 |
| 52-week low 3 | 0.190 |
| 50-day moving average 3 | 0.204 |
| 200-day moving average 3 | 0.222 |
Share statistics
| Avg vol (3-month) 3 | 62.44k |
| Avg vol (10-day) 3 | 91k |
| Shares outstanding 5 | 1.72B |
| Implied shares outstanding 6 | 1.72B |
| Float 8 | 683.35M |
| % held by insiders 1 | 53.33% |
| % held by institutions 1 | 0.00% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:20 |
| Last split date 3 | 21 Jan 2013 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Mar 2023 |
| Most-recent quarter (mrq) | 30 Sept 2023 |
Profitability
| Profit margin | 830.52% |
| Operating margin (ttm) | -166.68% |
Management effectiveness
| Return on assets (ttm) | -0.88% |
| Return on equity (ttm) | 18.42% |
Income statement
| Revenue (ttm) | 7.66M |
| Revenue per share (ttm) | 0.00 |
| Quarterly revenue growth (yoy) | -9.90% |
| Gross profit (ttm) | N/A |
| EBITDA | -17.68M |
| Net income avi to common (ttm) | 63.65M |
| Diluted EPS (ttm) | -0.110 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 862k |
| Total cash per share (mrq) | 0 |
| Total debt (mrq) | 1.04B |
| Total debt/equity (mrq) | 312.72% |
| Current ratio (mrq) | 0.02 |
| Book value per share (mrq) | -0.41 |
Cash flow statement
| Operating cash flow (ttm) | -19.16M |
| Levered free cash flow (ttm) | -168.82M |
© 2024 Yahoo. All rights reserved.